Eloxx Pharmaceuticals Inc (ELOX)

[Renee]

SVOND changed to ELOX:

http://otce.finra.org/DLSymbolNameChanges

[molee]

Some buys in anticipation ? ....

Maybe a press release to launch their new start ?

GLTus

[molee]

SVOND to ELOX tomorrow .....

http://otce.finra.org/DLSymbolNameChanges

[ddbl_our_buck]

..silence is [not] golden! Hard earned dollers are hard to invest in a 6.65 upside 7? Downside 4.5?? idk
Some funding news or share stux wb helpful to have a go at it.. might be looking at post position here?
New symbol? Excitement meter?
1-10? 6 leaning 7
Gl

[molee]

Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference

WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. ("Eloxx") (OTC:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare genetic diseases caused by nonsense mutations today announced that Robert ("Bob") Ward will participate in a panel entitled "What it Means to be in the Era of Cures" on Tuesday, January 9, 2018 at Biotech Showcase™ 2018 at 12:00-1:45 pm P.T. at the Hilton San Francisco Union Square.

http://www.nasdaq.com/press-release/eloxx-pharmaceuticals-chairman-and-ceo-robert-ward-to-participate-in-a-panel-discussion-at-the-20180104-00715

[molee]

What are these guys doing ? Anything ?

[terry hallinan]

Sevion Therapeutics Inc. changed to Eloxx Pharmaceuticals Inc. and a one for 20 reverse split:

It's a lot more than that, Renee.

It's a reverse merger of Sevion into Eloxx.

What happens to Sevion's IP?

Funny you should ask?

BTW with the loss of most orphan drug benefits under the rubric of reform, I can't see any incentive for Eloxx to maintain an outpost in America.

Best, Terry

[Renee]

Sevion Therapeutics Inc. changed to Eloxx Pharmaceuticals Inc. and a one for 20 reverse split:

http://otce.finra.org/DLSymbolNameChanges

[davidsson10]

1:20 R/S Tomorrow, per FINRA: http://otce.finra.org/DailyList

SVOND

[thought013]

Anticipated Closing Date is Dec 18th.

[charliewho]

Sooooo close here.... need volume for the break

[ddbl_our_buck]

I'm reading the latest news. Trying to compare what changed. DD on ELOXX due but off to work..
..This was the news before the news..

On May 31, 2017, the Company entered into an agreement (the “Agreement”), which was amended on August 1, 2017, with Sevion Acquisition Co. Ltd., an Israeli company and the Company’s wholly-owned subsidiary (“Acquisition Subsidiary”), and Eloxx Pharmaceuticals Ltd., an Israeli company (“Eloxx”), pursuant to which Eloxx will merge with and into Acquisition Subsidiary, with Eloxx surviving as the Company’s wholly-owned subsidiary (the “Transaction”). Consummation of the Transaction is subject to certain closing conditions, including, among other things: (i) approval of the Transaction by the stockholders of Eloxx; (ii) the successful consummation of separate equity financings resulting in cash investments in the Company’s business and Eloxx of no less than $12,000,000 each (the ”Financing Covenant”); (iii) the entering into a lockup agreement and registration rights agreement by and among the Company, certain of the Company’s shareholders and certain holders of Registrable Securities (as defined in the Agreement); (iv) the use by the Company of reasonable best efforts to up-list its Common Stock to The Nasdaq Capital Market; (v) delivery to Eloxx of executed resignation letters by each of the Company’s directors and officers, with an effective date to be as agreed upon by the Company and Eloxx; (vi) the adoption by the Company of an amendment to its certificate of incorporation to change its corporate name to Eloxx Pharmaceuticals, Inc.; and (vii) conversion of all of the Company’s issued and outstanding shares of preferred stock into shares of its Common Stock. Pursuant to the Agreement, the Transaction must close, if it closes, on or prior to December 31, 2017.

[TrendTrade2016]

sure is//the only way i trade em is if the weekly trend in on!!

[charliewho]

Love this weekly chart

[TrendTrade2016]

Get ready for lift off//53c

[Idunno]

They’ve bought it up this far...I don’t think it’s over... guessing .40 and higher going into the split...

[stocktrademan]

SVON buy 0.3600

bullish divergence
macd zero crossup
macd histogram crossup
resistance breakout
high volume confirmation
above the ichimoku clouds


















normal chart




log chart

[atotalbum]

lol

[Idunno]

....including the closing print:312,500

[Idunno]

Nice day, holy smokes, and ‘wow’ worthy.

[bb money]

You know me sold early after selling late on the last run- ha.

[atotalbum]

nice day !

[Idunno]

Trend, you saw this in January, when insiders first started buying. So did I. Good job. This buying action is very comforting. They are bidding this up into the RS. What this really shows is 1) confidence in ELX-02, and, 2) that we will be tightly held/ low float. I love the idea of a low float, tightly held stock, in conjunction with the potential of Eloxx....and they didn’t get the recent European patent for nothing. Things look good.......folks in the know are wanting to own, it seems.

[TrendTrade2016]

next stop 53 cents!!

[TrendTrade2016]

here comes the .39 resistance

[Idunno]

Eloxx has everything to do with the RS. Correct me if I’m wrong. We will issue lots and lots of new shares, so we can give Eloxx 70% of it/our stock. In return, we get/become Eloxx, ELX-02, and 38 million dollars, to bring ELX-02 to market. We become a new company, funded sufficiently, I presume, to establish ELX-02 efficacy and, if so, bring same to market. If we prove efficacy, I dunno, were worth (well) North of a billion dollars. RS away. We lose the penny stock label, we lose a couple hundred million shares, and we become a low float, actual, viable, promising entity. Reverse split as large as possible, IMO. Just this once, but now is the time. This is not a typical RS situation. This is a transformative occasion, and if ELX-02 works, we are parabolic to the upside. IMO.

[Idunno]

A little pre RS buying....

[terry hallinan]

Not that it matters (!) ... I’m revising my guess to a 1 for 20 RS

Sure seems to me like the tail wagging the dog. That is not a denial really but the only substantial IP value is in Eloxx from appearances. Eloxx has nothing to do with the price manipulation.

In a bygone era a tired flour miller and chicken and egg purveyor was bought by a man with a formula that would make the ne'er-do-well tiny conglomerate a giant.

I went along for the joy ride because I liked the elegant math that had recalibrated the chicken and egg cycle but sold when the chicken man had his minnow swallow a sick whale from a desperate conglomerate. Banquet Frozen food made TV dinners as tasteless as the Brady Bunch. It was paid for with an IOU as worthless as a current election tip from Nate Silver, a worn out former election and baseball wizard. As best I can gather his sabermetrics were no great shakes

I took a double, or triple, or quadruple, whatever on the former minnow trying to digest a sick whale. Pocket change.

Bad, awful, terrible, rotten move - like so many others.

That sick chicken turned into a monster winner that made the terrible TV dinners almost edible and provided an outlet for its contract chicken farmers. Today it is still Con Agra and the man with the formula has served his time in the pen for giving stock tips in D. C. to a lady of the night.

Good math is hard to beat but there's no percentage in foul p;ay.

Technicals aren't worth a used TV dinner except in the hands of people like Nate Silver once was with great ESP.

JMO. Real people think I'm nuts but I am occasionally right on other tiny tots like SVON. I might even buy some more but there are other chickies out there too.

Good luck, all and don't ever believe that atrocious advice to always take a profit. Those are lies spread by brokers and MM's.

Best, Terry

[Idunno]

Not that it matters (!) ... I’m revising my guess to a 1 for 20 RS, after issuance of shares. I’m thinking that leaves us with a nice low number of shares outstanding/float, after all settles.UHD, that could be good for you, as it will leave room to fall, if that’s what will be. If so, I’ll bite on some more with you.
Terry, thanks for the input! I like your thinking/analogies. I’m an old time options guy....premium buyer (strike out most of the time, hit a homer every (blue moon) now and then). Premium sellers, they win most of the time, get carried out once in a while. This is “low”/quantifiable risk (lose all/zero), high reward. I’m used to it. Good trading in the meantime, to all.

[UHD]

I will wait until after the rs

[terry hallinan]

All based on Frosts merger trends nothing to do with the science

Certainly a history of failure - or success - is a reasonable omen for the future. I say "omen" because it is impossible to quantify IMO.

As a once well-known example, the now immortal baseball manager Casey Stengel during the peak of the reign of the NY Yankees was claimed to be the most-fired major league baseball manager ever before the Yankees hired him.

Failure is far more common than success in scientific advancement. The most successful investor in biotech fails often and SVON is already an example. SVON was formed from the remains of very "successful" GMO developments that could not be sold of the rampant superstition and the orihinal SVON with its humanized cow antibodies that were supposed to be far superior to the Creator's human antibodies that could get into the crooks and crannies. The new Eloxx, assuming the merger occurs, will get little but a bit of cash and a smattering of other assets.

Frost has become the most successful biotech investor ever not because he seldom fails like Warren Buffett but because he fails less often than others.

As I see it, the current SVON is a cheap moonshot most likely to fail.

JMO.

Best, Terry

[UHD]

All based on Frosts merger trends nothing to do with the science

[terry hallinan]

Similar to VBIV and BCDA.

Like mice are similar to elephants in that both have 4 legs, UHD?

Please try forgive the sarcasm. I am quite well aware of the plain fact few investors in scientific R&D know or care much about the science with that being particularly true of shorts.

Aside from VBIV's glioblastoma cancer vaccine with dim prospects in my unresearched opinion, the pair are not remotely like the Israeli biotech hoping to find a cure [cure, not treatment] for nonsense diseases like the many varieties of muscular dystrophy.

All nonsense diseases [name derived from antisense lingo that is a classification of catastrophic diseases resulting from incomplete DNA] are very rare but I think cystic fibrosis is the most common and most devastating, maybe because of a cousin in Ireland who had the disease.

Ignoring my own bias, surely any sentient beings interested in news of even the tabloid variety would have had trouble missing the excitement caused by a dubious treatment for a single variety of muscular dystrophy.

Well yeah, but will Eloxx, the new Sevion if all goes according to plan, cure any nonsense diseases?

- Most likely not given grim statistical odds but the odds themselves are dubious in such a case.

Just some dull thoughts for you more thrilled by chewing the rag.

Best, Terry

[UHD]

Similar to VBIV and BCDA. All Frost mergers with RS and all went down after RS

[Idunno]

In a way, this isn’t a typical RS situation, right? I’m not saying this won’t go down after the RS, who knows. RS will happen, new shares will be issued (Eloxx cut), stock will be adjusted...but we will also be an entirely new entity, funded/cash at about 38 million dollars, I believe, to bring to market, I’m hopeful, an innovative new approach to a variety of unmet medical needs, with considerable upside, if proven as to efficacy. So, In what is an an unusual feeling for me, I’m okay with a larger RS. We have something of value here, finally, I think. We will see.

[UHD]

R/S no less than 1 for 2 and no more than 1 for 100! Going to wait for rhe dust to clear and see how far it goes down after RS

[noreen]

.20 to .32 on NO news in 4 trading days?

What is going on here? What did I miss?

[TrendTrade2016]

first resistance at .35 then take on .39

[flacrusher]

Sure looks like it.

[TrendTrade2016]

SVON breaking out

[flacrusher]

Volume starting to come in. Good to see.

[infunf]

Nice!

[atotalbum]

yep lookin good wonder if frost went buying

[bb money]

Lots of volume past two trading days.

[bb money]

I should have flipped at .30 but held. Think this has a nice run at some point and may get more here as this was my last entry point.

[atotalbum]

I hopped back in at .20

[terry hallinan]

Are people supposed to be hoping revenue will be on the 10q...or is that not yet?

Morning, Infunf.

"Not yet" definitely, I would say.

SVON's preclinical and legacy technology is about to be swallowed up by Eloxx which is contemplated at 70% of assets after a kind of reverse merger before additional funding presumably attracted primarily, if not exclusively, by Eloxx's research on rare nonsense diseases, headlined by cystic fibrosis and muscular dystrophy.

http://tinyurl.com/KindleWireless

The odd nomenclature of "nonsense diseases" derives from antisense technology denoting a class of inherited genetic defects that essentially come from defective or missing DNA:

http://tinyurl.com/y77hnrty

That may or may not be helpful to you but I am sure you and others must realize that the erstwhile popularly-misnamed anti-GMO technology I originally bought years ago has left little but ashes after destruction by the delusional vampire hunters. That battle is long over here and maybe the Sevion technology will fare no better but Eloxx may have a huge winner eventually with emphasis on MAY and EVENTUALLY.

JMO.

Best, Terry

[infunf]

1 yr ascending triangle

[infunf]

Are people supposed to be hoping revenue will be on the 10q...or is that not yet?

[bb money]

Looks like some accumulation going on at the moment.